» Articles » PMID: 39300511

Informed Consent and Coercion in Recruitment Advertisements for Oocyte Donors

Overview
Publisher Biomed Central
Date 2024 Sep 19
PMID 39300511
Authors
Affiliations
Soon will be listed here.
Abstract

Background: As the use of donor eggs for in vitro treatment has increased, both medically affiliated and private donor egg agencies have turned to online advertisements to recruit donors. The American Society for Reproductive Medicine provides recommendations encouraging ethical recruitment of donors, however there is no formal regulation for the informed consent process for egg donor recruitment and compensation. Underrepresentation of risks and targeted financial incentives may pose a risk to the informed consent process.

Methods: Data from online advertisements for egg donors active between January 1 - August 31, 2020, were collected to analyze content related to risks, Covid-19 precautions, donor payment, and desired donor characteristics. Advertisements for egg donors on Google, Craigslist, and social media were analyzed. Primary outcomes included the mention of the risks of egg donation, including the risk of Covid-19 exposure, in donor egg advertisements. Secondary outcomes included language targeting specific donor characteristics and financial compensation.

Results: 103 advertisements were included. 35.9% (37/103) of advertisements mentioned some risk of the egg donation process, and 18.5% (19/103) mentioned risks or precautions related to Covid-19 exposure. Of advertisements for private donor egg agencies, 40.7% (24/59) mentioned any risk, compared to 29.6% (13/44) of medically affiliated egg donation programs; the difference was not statistically significant (p-value = 0.24). Agencies targeting students and donors of a specific race were more likely to offer payments over $10,000 for an egg donation cycle. Among advertisements offering over $20,000 for donor compensation, 72.7% (8/11) recruited women under the age of 21.

Conclusion: Egg donor recruitment advertisements, for both medically affiliated programs and private agencies, were unlikely to mention risks including the risk of exposure to Covid-19. Non-medically affiliated private donor egg agencies were more likely to violate multiple American Society for Reproductive Medicine ethics guidelines, including offering higher than average compensation, and recruiting donors from young and vulnerable populations.

References
1.
Lafuente-Funes S, Weis C, Hudson N, Provoost V . Egg donation in the age of vitrification: A study of egg providers' perceptions and experiences in the UK, Belgium and Spain. Sociol Health Illn. 2022; 45(2):259-278. PMC: 10100196. DOI: 10.1111/1467-9566.13590. View

2.
. Financial compensation of oocyte donors: an Ethics Committee opinion. Fertil Steril. 2017; 106(7):e15-e19. DOI: 10.1016/j.fertnstert.2016.09.040. View

3.
Krawiec K . Egg-donor price fixing and Kamakahi v. American Society for Reproductive Medicine. Virtual Mentor. 2014; 16(1):57-62. DOI: 10.1001/virtualmentor.2014.16.01.pfor1-1401. View

4.
Bodri D, Guillen J, Polo A, Trullenque M, Esteve C, Coll O . Complications related to ovarian stimulation and oocyte retrieval in 4052 oocyte donor cycles. Reprod Biomed Online. 2008; 17(2):237-43. DOI: 10.1016/s1472-6483(10)60200-3. View

5.
Alberta H, Berry R, Levine A . Risk disclosure and the recruitment of oocyte donors: are advertisers telling the full story?. J Law Med Ethics. 2014; 42(2):232-43. DOI: 10.1111/jlme.12138. View